Hervé Rhinn

Person

New York, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-MS4A6A antibodies and methods of use thereof
- Patent number 12,215,149
- Issue date Feb 4, 2025
- ALECTOR LLC
- Philip Kong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene therapy for neurodegenerative disorders
- Patent number 12,049,626
- Issue date Jul 30, 2024
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,999,974
- Issue date Jun 4, 2024
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- G01 - MEASURING TESTING
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,993,790
- Issue date May 28, 2024
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,903,985
- Issue date Feb 20, 2024
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,807,849
- Issue date Nov 7, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,802,294
- Issue date Oct 31, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-MS4A4A antibodies and methods of use thereof
- Patent number 11,667,699
- Issue date Jun 6, 2023
- ALECTOR LLC
- Jeonghoon Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,661,585
- Issue date May 30, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,655,460
- Issue date May 23, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,613,737
- Issue date Mar 28, 2023
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-MS4A4A antibodies and methods of use thereof
- Patent number 11,472,874
- Issue date Oct 18, 2022
- ALECTOR LLC
- Philip Kong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TMEM106B antibodies and methods of use thereof
- Patent number 11,440,957
- Issue date Sep 13, 2022
- ALECTOR LLC
- Arnon Rosenthal
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD33 antibodies and methods of use thereof
- Patent number 11,136,390
- Issue date Oct 5, 2021
- ALECTOR LLC
- Kate Monroe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 11,060,113
- Issue date Jul 13, 2021
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 10,837,028
- Issue date Nov 17, 2020
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapies for lysosomal disorders
- Patent number 10,689,625
- Issue date Jun 23, 2020
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized miRNA constructs
- Patent number 9,290,759
- Issue date Mar 22, 2016
- The Trustees of Columbia University In the City of New York
- Asa Abeliovich
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
GENE THERAPY FOR NEURODEGENERATIVE DISORDERS
- Publication number 20250011783
- Publication date Jan 9, 2025
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SOLUBLE CD33 AS A BIOMARKER FOR ANTI-CD33 EFFICACY
- Publication number 20240329054
- Publication date Oct 3, 2024
- ALECTOR LLC
- Robert PAUL
- G01 - MEASURING TESTING
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20240287471
- Publication date Aug 29, 2024
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- G01 - MEASURING TESTING
Information Patent Application
ANTI-TMEM106B ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20240174746
- Publication date May 30, 2024
- ALECTOR LLC
- Eric BROWN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TMEM106B ANTIBODIES FOR TREATING AND PREVENTING CORONAVIRUS IN...
- Publication number 20240166738
- Publication date May 23, 2024
- ALECTOR LLC
- Herve RHINN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20240123003
- Publication date Apr 18, 2024
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20240076362
- Publication date Mar 7, 2024
- ALECTOR LLC
- Jeonghoon SUN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TMEM106B ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20230303681
- Publication date Sep 28, 2023
- ALECTOR LLC
- Arnon ROSENTHAL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20230287358
- Publication date Sep 14, 2023
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20230142579
- Publication date May 11, 2023
- ALECTOR LLC
- Philip KONG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20230126400
- Publication date Apr 27, 2023
- ALECTOR LLC
- Philip KONG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-MS4A6A ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20220380455
- Publication date Dec 1, 2022
- ALECTOR LLC
- Philip KONG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD33 ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20220251190
- Publication date Aug 11, 2022
- ALECTOR LLC
- Kate MONROE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20220211871
- Publication date Jul 7, 2022
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
GENE THERAPIES FOR NEURODEGENERATIVE DISEASE
- Publication number 20220010001
- Publication date Jan 13, 2022
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20210332385
- Publication date Oct 28, 2021
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENE THERAPIES FOR NEURODEGENERATIVE DISEASES
- Publication number 20210261981
- Publication date Aug 26, 2021
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-MS4A6A ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20210122817
- Publication date Apr 29, 2021
- ALECTOR LLC
- Philip KONG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20210079074
- Publication date Mar 18, 2021
- ALECTOR LLC
- Jeonghoon SUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20210040200
- Publication date Feb 11, 2021
- ALECTOR LLC
- Philip KONG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20210010032
- Publication date Jan 14, 2021
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20200338148
- Publication date Oct 29, 2020
- Prevail Therapeutics, Inc.
- Asa Abeliovich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TMEM106B ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20200339680
- Publication date Oct 29, 2020
- ALECTOR LLC
- Arnon ROSENTHAL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20200332265
- Publication date Oct 22, 2020
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20200318115
- Publication date Oct 8, 2020
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20200308554
- Publication date Oct 1, 2020
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20200282080
- Publication date Sep 10, 2020
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPIES FOR NEURODEGENERATIVE DISEASES
- Publication number 20200283800
- Publication date Sep 10, 2020
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20200276335
- Publication date Sep 3, 2020
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENE THERAPIES FOR LYSOSOMAL DISORDERS
- Publication number 20200231954
- Publication date Jul 23, 2020
- Prevail Therapeutics, Inc.
- Asa ABELIOVICH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Hervé Rhinn

Person

Patents Grantslast 30 patents

Anti-MS4A6A antibodies and methods of use thereof

Gene therapy for neurodegenerative disorders

Gene therapies for lysosomal disorders

Gene therapies for lysosomal disorders

Gene therapies for lysosomal disorders

Gene therapies for lysosomal disorders

Gene therapies for lysosomal disorders

Anti-MS4A4A antibodies and methods of use thereof

Gene therapies for lysosomal disorders

Gene therapies for lysosomal disorders

Gene therapies for lysosomal disorders

Anti-MS4A4A antibodies and methods of use thereof

Anti-TMEM106B antibodies and methods of use thereof

Anti-CD33 antibodies and methods of use thereof

Gene therapies for lysosomal disorders

Gene therapies for lysosomal disorders

Gene therapies for lysosomal disorders

Optimized miRNA constructs

Patents Applicationslast 30 patents

GENE THERAPY FOR NEURODEGENERATIVE DISORDERS

SOLUBLE CD33 AS A BIOMARKER FOR ANTI-CD33 EFFICACY

GENE THERAPIES FOR LYSOSOMAL DISORDERS

ANTI-TMEM106B ANTIBODIES AND METHODS OF USE THEREOF

ANTI-TMEM106B ANTIBODIES FOR TREATING AND PREVENTING CORONAVIRUS IN...

GENE THERAPIES FOR LYSOSOMAL DISORDERS

ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF

ANTI-TMEM106B ANTIBODIES AND METHODS OF USE THEREOF

GENE THERAPIES FOR LYSOSOMAL DISORDERS

ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF

ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF

ANTI-MS4A6A ANTIBODIES AND METHODS OF USE THEREOF

ANTI-CD33 ANTIBODIES AND METHODS OF USE THEREOF

GENE THERAPIES FOR LYSOSOMAL DISORDERS

GENE THERAPIES FOR NEURODEGENERATIVE DISEASE

GENE THERAPIES FOR LYSOSOMAL DISORDERS

GENE THERAPIES FOR NEURODEGENERATIVE DISEASES

ANTI-MS4A6A ANTIBODIES AND METHODS OF USE THEREOF

ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF

ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF

GENE THERAPIES FOR LYSOSOMAL DISORDERS

GENE THERAPIES FOR LYSOSOMAL DISORDERS

ANTI-TMEM106B ANTIBODIES AND METHODS OF USE THEREOF

GENE THERAPIES FOR LYSOSOMAL DISORDERS

GENE THERAPIES FOR LYSOSOMAL DISORDERS

GENE THERAPIES FOR LYSOSOMAL DISORDERS

GENE THERAPIES FOR LYSOSOMAL DISORDERS

GENE THERAPIES FOR NEURODEGENERATIVE DISEASES

GENE THERAPIES FOR LYSOSOMAL DISORDERS

GENE THERAPIES FOR LYSOSOMAL DISORDERS